Results and discussion
To test whether RuvA, RuvB and RuvC form a distinct multisubunit complex containing all three polypeptides, interactions between the three purified proteins were analysed. Monoclonal antibodies raised against each protein were used to pull down complexes, which were subsequently analysed by SDS-PAGE and western blotting using a mixture of rabbit anti-RuvA, anti-RuvB and anti-RuvC polyclonal antibodies. . Similarly, when RuvB and RuvC were mixed, we failed to detect RuvC protein when immunoprecipitating with the anti-RuvB monoclonal antibody (Figure 1b, lane 7) . Immunoprecipitation of RuvC by the anti-RuvC antibody was found to be hindered by the presence of RuvB, however (Figure 1c, compare lanes 1 and  7) . Because the two proteins aggregate in solution (A.H. Mitchell, A.A.D. and S.C.W., unpublished observations) and because RuvB was present in a fivefold molar excess over RuvC, it is likely that most of the RuvC was associated with RuvB, forming aggregates that were inaccessible to the anti-RuvC antibody. As expected, most of the RuvB Figure 1 Coimmunoprecipitation of RuvABC. Combinations of the three Ruv proteins (A, B and C) were incubated without DNA (-), with duplex DNA (D) or with Holliday junction X0 DNA (X). Reactions (200 µl) contained 50 mM Tris-acetate pH 8.0, 20 mM KOAc, 1 mM EDTA, 100 µg/ml bovine serum albumin (BSA; Sigma) and, where indicated, DNA (100 nM). RuvA (250 nM) was incubated for 3 min at 37°C, followed by RuvC (500 nM) for 5 min, and RuvB (2.5 µM) for a further 30 min. After incubation, 50 µl BSA (50 mg/ml) was added and protein-DNA complexes were immunoprecipitated (IP) using 20 µg (a) anti-RuvA, (b) anti-RuvB or (c) anti-RuvC monoclonal antibodies coupled to protein-G-Sepharose beads (Pharmacia) using dimethyl pimelimidate (Sigma). Complexes were analysed by SDS-PAGE followed by western blotting with a mixture of rabbit anti-RuvA, antiRuvB and anti-RuvC polyclonal antibodies using enhanced chemiluminescence (ECL) detection (Amersham). The polypeptide that migrates between RuvA and RuvB is a degradation product of RuvB. When interactions between all three proteins were examined, a RuvAB complex was detected when immunoprecipitating with either the anti-RuvA or the anti-RuvB monoclonal antibodies (Figure 1a ,b lane 10). RuvC was not detected because immunoprecipitation of RuvC by the RuvC monoclonal antibody was again inhibited by the presence of RuvB (Figure 1c, compare lanes 1 and 10) . We conclude that RuvA and RuvB form a stable complex in solution, but find no evidence for a RuvABC complex under these conditions. Because a Holliday junction may provide a scaffold that allows the assembly of a functional RuvABC complex, immunoprecipitations were carried out in the presence of DNA. A synthetic Holliday junction was prepared by annealing four 60-mer oligonucleotides. The Holliday junction (X0) used in this experiment contained an immobile junction point and was resistant to cleavage by RuvC. In the presence of junction X0, RuvA formed a complex with RuvC that was immunoprecipitated with the antiRuvA (Figure 1a, lane 9) or the anti-RuvC (Figure 1c Figure 1c , lane 5). Using 32 P-labelled junctions in the immunoprecipitation experiments, we found that the RuvA and RuvC proteins were indeed bound to DNA (data not shown), confirming earlier findings that synthetic Holliday junctions can be bound simultaneously by RuvA and RuvC [5] .
The identification of a RuvAC-junction complex is significant, as its formation might represent an important stage in the transition between RuvAB-mediated branch migration and RuvC-mediated cleavage. Alternatively, the structure could be part of a larger RuvABC-junction complex. We therefore attempted to coimmunoprecipitate RuvABC complexes with Holliday junction DNA. Remarkably, we found that all three monoclonal antibodies pulled down a complex containing RuvA, RuvB and RuvC (Figure 1, lane 12 of panels a,b,c) . When the junctions were replaced by duplex DNA, RuvABC complexes were not observed (Figure 1, lane 11 of panels a,b,c) .
Because it was possible that the immunoprecipitates contained Holliday junction complexes consisting of a mixture of RuvAB, RuvAC and RuvBC complexes rather than a single complex comprising all three proteins, control experiments were carried out to determine whether RuvBC complexes could be immunoprecipitated in the absence of RuvA. No evidence for the presence of a stable RuvBC-Holliday junction complex was obtained (Figure 1b,c, lane 9) . These results provide the first physical evidence for the existence of a specific RuvABC-Holliday junction complex.
In all of these experiments, each protein was added in a predetermined order. In general, addition of RuvA to the junction before RuvC produced complexes that were more stable (Figure 2a, lanes 4-6) , whereas addition of RuvC before RuvA inhibited complex formation (Figure 2a, lanes  1-3) . Complex formation was optimal when RuvB protein was added last (Figure 2a, lane 5) . The amount of RuvC in the RuvABC complex detected in Figure 1 (lane 12) and Figure 2a (lanes 4-6) appeared to be less than either RuvA or RuvB. Controls in which equal amounts of the three proteins were loaded onto a gel showed that RuvC was poorly antigenic, however (Figure 2b ).
RuvC interacts specifically with Holliday junctions to form a complex in which the DNA lies in a twofold symmetric open configuration [10] . In contrast, RuvA-junction complexes exhibit fourfold symmetry [11, 12] . This difference may explain why RuvA failed to form a RuvAC-junction complex when the junction had been prebound by RuvC, as RuvA may not be able to bind a twofold symmetric RuvC-junction complex. These data indicate that RuvA binding is required before RuvC to impose fourfold symmetry on the junction; this structure is subsequently bound by RuvC.
To determine whether the complex could be detected under conditions in which the proteins were functionally active, related experiments were carried out using a cleavable Holliday junction (X4) [7] . To favour Holliday junction resolution in the presence of limited branch migration, the reaction buffer contained Mg 2+ and a mixture of ATP and ATPγS [7] . Control experiments, carried out in the The uncleavable X0 junction did not show this difference (Figure 3b, lanes 1,2) , indicating that the RuvABC complex dissociates from the DNA upon resolution.
Two models have been proposed to explain how branch migration and resolution might be coordinated to allow RuvC to be targeted to potential cleavage sites: firstly, RuvAB may promote branch migration and dissociate at DNA sequences that are suitable for cleavage by RuvC, or, secondly, the RuvABC proteins may form a junctionspecific complex that is capable of both branch migration and resolution [5, 6, [12] [13] [14] . The data presented here provide direct evidence for the existence of a RuvABC-Holliday junction complex and support the second proposal. The precise nature and subunit composition of this complex remains to be elucidated.
